L'Oréal


Outlook not encouraging enough for FY20

31/07/20 -"Despite the strong rebound in China, all divisions have been heavily impacted by the pandemic in the last three months, especially those with the greatest exposures to makeup products which have been ..."

Pages
41
Language
English
Published on
31/07/20
You may also be interested by these reports :
07/08/20
The skin envelopes the human body and regulates, amongst other ‘tasks’, moisture. In work-from-home times, wrinkles are accepted more. Having ...

06/08/20
Six months into the crisis, the effects have intensified although the pattern has not changed compared to Q1: Adhesive Technologies suffered the most ...

05/08/20
Reckitt reported strong H1 20 results, beating consensus as well as our estimates. Sales were up 11.9%, driven by Hygiene (+16.1%) and other health ...

31/07/20
Despite the strong rebound in China, all divisions have been heavily impacted by the pandemic in the last three months, especially those with the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO